A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes.
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,086 other S bills in the 116th — cohort avg 30d
This bill waives certain eligibility requirements for hospitals participating in the 340B drug discount program (i.e., a program that allows entities to receive covered outpatient drugs at reduced prices from manufacturers) during the COVID-19 (i.e., coronavirus disease 2019) public health emergency. Specifically, the bill waives the required minimum proportion of low-income patients served for hospitals that began participating in the program during or prior to the COVID-19 emergency.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (14)
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S4225-4226)
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2020 · third_quarter · Health Issues
P.L. 116-136, Coronavirus Aid, Relief, and Economic Security (CARES) Act - provisions related to infusion issues for Medicare patients, amendments to the Tax Cuts and Jobs Act (TCJA) and the orphan drug tax credit; Issues related to the use of plasma therapies in COVID-19 patients; Communications with DFC regarding Project Warp Speed - provisions related to use of plasma to treat COVID-19; H.R. 1425, The Patient Protection and Affordable Care Enhancement Act Discussions to clarify or reform the 340B program; S.4160 - A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes - provisions to clarify or reform the 340B program; Discussions on value-based drug contracting; Proposals related to drug pricing, including House and Senate draft bills; H.R. 1035; Prescription Drug Price Transparency Act - provisions related to drug pricing transparency and pharmacy benefit managers; S. 378, H.R. 1093, The Stop Price Gouging Act - provisions related to prescription drug pricing; Discussions related to co-pay accumulators; S. 657, Drug Price Transparency Act - provisions related to prescription drug pricing transparency and commercial market rebates; H.R. 2279, S. 2546, Safe Step Act - provisions related to step therapy policy; H.R. 3276, S. 1785, Fair AMP Act - provisions related to AMP cap, exclusion of authorized generics from AMP; H.R. 3, Lower Drug Costs Now Act of 2019 - provisions related to the establishment of programs and requirements relating to the prices of prescription drugs; H.R. 19, Lower Costs, More Cures Act of 2019 - provisions related to AMP cap removal, Medicare Part D redesign, exclusivity periods, vial wastage, drug price transparency, add-on payment and pay-fors; VA MISSION Act of 2018 (P.L. 115 - 182) - provisions related to healthcare coverage after dischange from active duty; H.R. 5201, Telemental Health Expansion Act of 2019 - provisions related to mental telehealth coverage; Issues related to global pharmaceutical supply chain operations and manufacturing locations; H.R. 2507, S. 2158, Newborn Screening Saves Lives Reauthorization of 2019 - provisions related to newborn screening; H.R. 6800, The Heroes Act - provisions related to tax issues and plasma treatments; Discussions related to Most Favored Nation/International Reference Pricing including the Executive Order; E.O. 13937, Access to Affordable Life-Saving Medications; E.O. 13938, Increasing Drug Importation to Lower Prices for American Patients; E.O. 13939, Lowering Drug Prices by Eliminating Kickbacks to Middlemen; E.O. 13947, 13948, Lowering Drug Prices by Putting America First; E.O. 13944, Combating Public Health Emergencies and Strengthening National Security by Ensuring Essential Medicines, Medical Countermeasures, and Critical Inputs are Made in the United States; E.O. 13951, An America-First Healthcare Plan; E.O 13950, Combating Race and Sex Stereotyping.
Client expense: $1,190,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2020 · fourth_quarter · Health Issues
Issue: Educate Congress and the administration on academic medicines missions, including education, research, patient care, GME, workforce, and physician shortages in rural and urban communities. Draft Bipartisan Emergency COVID Relief Act of 2020 H.R. 6650, S. 3634, Health Heroes 2020 Act S. 4055, Strengthening Americas Health Care Readiness Act Issue: Support increased funding for the National Health Service Corps, and National Disaster Medical Service (NDMS) demonstration pilot. Issues: Educate Congress and the administration about academic medicines response to the opioid epidemic. Support funding for training on substance use disorders, pain management, and safe prescribing practices. Support suspension of DATA waivers. Support continuation of telehealth flexibilities allowing authorized practitioners to prescribe buprenorphine. P.L. 116-22, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 Issues: Support the Hospital Preparedness Program and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Support increased funding authorization levels. Issue: Support high-quality affordable health insurance. Support programs and funds for safety-net providers. Issue: Support measures to preserve and strengthen the 340B Drug Pricing Program and oppose efforts to reduce the scope of the program, including instituting a moratorium, increasing reporting requirements on covered entities, imposing user fees, changing the program from an up-front discount to a post-sale rebate, and not providing 340B discounts on covered drugs purchased at community pharmacies. Issue: Oppose efforts to create new requirements for FQHC grantees that participate in the 340B program. Issue: Oppose efforts to reduce OPPS reimbursements to hospitals for drugs acquired under the 340B program. Issue: Oppose efforts to allow certain grandfathered health care plans to increase consumer cost sharing without losing their grandfathered status. Issue: Oppose State relief and empowerment waivers that allow states to offer insurance plans that do not meet the requirements set forth under the Affordable Care Act. Issue: Oppose efforts to expand the availability of Association Health Plans. Issue: Oppose efforts to direct HHS to update the Medicare.gov Hospital Compare website. Issue: Support increased interoperability and exchange of electronic health information and delayed enforcement of information blocking rule until comprehensive guidance is issued. Issue: Oppose efforts to finalize two new mandatory alternative payment models, the Radiation Oncology Model and the End-stage Renal Disease Treatment Choices Model Issue: Oppose burdensome regulation of Laboratory Developed Tests S. 1895, Lower Health Care Costs Act H.R. 3630, No Surprises Act S. 1531, Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 H.R. 3502, Protecting People From Surprise Medical Bills Act Issues: Educate Congress on surprise medical bills and price transparency or disclosure. Support general principles for surprise medical bills draft legislation. Oppose statutory benchmark rate setting. Oppose Senate hospital/insurer contracting provisions and onerous reporting burden. S. 1895, Lower Health Care Costs Act, Title IV Issue: Prescription drug pricing, public health, maternal mortality, and health information technology. Issue: Oppose restrictions on diversity training for federal grantees and employees. Issue: Development of Enhanced Primary Care Pilot Act proposal Issue: Educate Congress about medical education on nutrition, consent, implicit bias, and maternal health. H.R. 6637, Health Equity and Accountability Act Issue: Support programs to improve health equity and address social determinants of health. Issue: Support initiatives of hospitals to promote affordable housing in local communities and eliminate other social determinants of health to improve health equity. P.L. 116-260, Consolidated Appropriations Act, 2021 H.R. 4004, S. 2986 Social Determinants Accelerator Act of 2019 Issue: Support grants to address social determinants of health Issue: Support congressional investment in the Centers for Medicare and Medicaid Innovation (CMMI) models to reduce maternal mortality and improve maternal health. H.R. 4995 Maternal Health Quality Improvement Act of 2020 H.R. 4996 Helping MOMS Act of 2020 Issue: Support maternal health initiatives to expand coverage for postpartum women and expand demonstration project grants. S. 3750/H.R. 6837, Medicare Accelerated and Advance Payment Improvement Act of 2020 Issue: Support improvements to the Medicare Accelerated and Advance Payment Programs. Draft, firearm safety legislation Issue: Support universal background checks, violence prevention programs, extreme risks protection orders, child access safety laws, and reinstating assault weapons ban. H.R. 8, Bipartisan Background Checks Act of 2019 Issue: Support universal background checks Issue: Support aligning 42 CFR Part 2 regulations with the Health Insurance Portability and Accountability Act (HIPAA) for the purposes of treatment, payment, and healthcare operations. S. 4349/H.R. 8094, Dr. Lorna Breen Health Care Provider Protection Act Issue: Support grants directed at improving physician burnout and well-being. P.L. 116-260, Consolidated Appropriations Act, 2021 P.L. 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020 P.L. 116-127, Families First Coronavirus Response Act P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES) Act H.R.6379, Take Responsibility for Workers and Families Act H.R. 6800, the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act Draft Health, Economic Assistance, Liability Protection and Schools (HEALS) Act S. 178 with Amendment No. 2652 HEALS Act S. 4322, Safely Back to School and Back to Work Act S. 178, Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act H.R. 8406, The Heroes Act Draft Emergency Coronavirus Relief Act of 2020 Draft Bipartisan State and Local Support and Small Business Protection Act of 2020 Issues: Support emergency supplemental funding and policies for federal agencies to support coronavirus preparedness, response, relief, vaccine development and distribution, and testing and contact tracing. Ensure access to research samples. Support funding for and provide recommendations for disbursement of provider relief fund. Support revised Medicare and Medicaid reimbursement policies and increased provider flexibility. Support improvements to the Medicare Accelerated and Advance Payment Programs. Support inclusion of Medicare-supported graduate medical education positions. Support fixes to Medicare GME Rural Training Track programs. Support Medicare GME per resident amount and cap-setting technical corrections and administrative relief. Support an increase in the Federal Medicaid Assistance Program. Support for current telehealth waivers to be made permanent. Support for extension of Medicare sequester moratorium. Support changes to CY 2021 Physician Fee Schedule evaluation and management payments. Provide recommendations on personal protective equipment, testing, social distancing, clinical care, and other COVID related preparedness and response efforts of the federal government. Avoid imposing standards that would encourage depletion of scarce PPE and other resources. Support enhanced national COVID-19 data collection to better address health disparities. Support public health infrastructure. See other additions under BUD. Issue: Support extension of public health emergency declaration. Issue: Provide feedback on COVID-19 and pandemic response centers of excellence legislation. Issue: Support establishment of regional pandemic response centers, stronger linkages between public health and academic medicine, and the role of medical students in administering covid vaccines. Issue: Urge establishment and implementation of robust national COVID-19 testing strategy and functional and transparent supply chain. Urge CDC to update testing guidelines. Issue: Describe medical education approach on womens health and support efforts to promote trauma-informed care. Issue: Support science and data driven approach to HHS and EPA decision making. Issue: Support CDC mission S 4248 / HR 7618 COVID-19 Bias and Anti-Racism Training Act Issue: Support grant for anti-racism training in health professions programs. H.R. 8017, Mobile Options for Testing In Our Neighborhoods (MOTION) Act Issue: Support grants for mobile COVID-testing units. S. 4160, To enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes. Issue: Support protections for hospitals that participate in the 340B Drug Pricing Program to temporarily allow them to remain eligible for the program. H.R. 8283 S. 4421, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act Issue: Support for a temporary uniform licensing standard for all practitioners in all states throughout a national emergency. Issue: Support the rescission of the Department of Homeland Securitys Public Charge rule. Issue: Participate in Resilient American Communities initiative S. 4740 Public Health Infrastructure Saves Lives Act Issue: Support investments in core public health infrastructure. Issue: Rescind the Executive Order on Creating Schedule F in the Excepted Service. Issue: Rescind Executive Orders 13771 and 13777, and support re-implementation of directives under Executive Order 13563, Improving Regulation and Regulatory Review. Issue: Support establishment of a Presidential Bioethics Commission. Issue: Support ensuring patients are put first and that conscience protections align with medical professionalism standards. Issue: Support prompt establishment of the Research Policy Board and implementation of the additional reform efforts required by Section 2034 of the 21st Century Cures Act (P.L. 114-255). Issue: Support increased interoperability and exchange of electronic health information. Support delay of enforcement beyond April 2021. Issue: Support identification of specific federal regulations for review for disproportionate administrative impacts. Issue: Support independence of the US Food and Drug Administration. Issue: Support FDA rulemaking to harmonize protection of human research subjects. Issue: Support promotion of data sharing and clinical trials results reporting.
2020 · fourth_quarter · Health Issues
Repeal of the Affordable Care Act Development of legislation to protect essential hospitals Issues related to telehealth Mental Health Essential Health Benefits created by the Affordable Care Act Access to hospital emergency services Issues related to the 340B Drug Pricing Program 340B dug pricing program CMS OPPS 340B rule moratorium-related legislation 42 CFR Part 2 CREATES Act-H.R.965 Cassidy Surprise Billing Draft Protecting Patients from Surprise Medical Bills Excellence in Metal Health Act (S.824/H.R.1767) Patient Centered Outcomes Research Institute Funding No Surprises Act Lower Health Care Costs Act Surprise Medical Bills H.R.4004 - Social Determinants Accelerator Act of 2019 S.2986 - Social Determinants Accelerator Act of 2019 H.R.2328 - Reauthorizing and Extending America's Community Health Act S.2723 - Mitigating Emergency Drug Shortages Act H.R.4995 - Maternal Health Quality Improvement Act of 2019 H.R.2889 - Closing Loopholes for Orphan Drugs Act 340B drug pricing program eligibility (Matsui-Stewart Dear Colleague letter) Relief for Rural Providers During Emergencies Act (S. 3631) Improving Social Determinants of Health Act (H.R. 6561) Liability reform Issues related to COVID-19 regulatory and financial relief COVID-19 Provider Relief Fund Resolution recognizing racism as public health issue - S. Res. 655 COVID-19 Bias and Anti-Racism Training Act - S. 4248 Protecting 340B eligibility during the pandemic - S. 4160 and HR 7838 Protect Telehealth Access Act of 2020 (HR 7391) Improving Social Determinants of Health Act - S. 4440 Maternal health 340B contract pharmacies (McKinley-DeGette-Gianforte-Matsui-Johnson-Welch Dear Colleague letter) 340B contract pharmacies (Baldwin-Capito-Cardin-Portman-Stabenow-Thune Dear Colleague letter) Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act Health disparities COVID-19 payroll tax credits 340B rebate Dear Colleague letter (Spanberger-McKinley-Axne-Johnson-Matsui-Katko)
2020 · fourth_quarter · Pharmacy
S 4160 and HR 7838 340B Enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the public health service act prior to the COVID-19 public health emergency to temporarily maintain eligibility for program
Client expense: $210,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Navy, Dept of, SENATE
2020 · fourth_quarter · Health Issues
Bill # H.R. 647 and S2080: Palliative Care and Hospice Education and Training Act. Establishes Palliative Care and Hospice Education Centers to increase access to palliative care Bill # H.R. 728: Title VIII Nursing Workforce Reauthorization Act.To amend title VIII of the Public Health Service Act to extend advanced education nursing grants to support clinical nurse specialist programs Bill # H.R. 1767 and S824: Excellence in Mental Health and Addiction Treatment Expansion Act. To increase the number of states that may conduct Medicaid demonstration programs to improve access to community mental health services Bill # H.R. 2062 and S1012: Overdose Prevention and Patient Safety Act.Amends the Public Health Service Act to protect the confidentiality of substance use disorder patient records Bill # H.R. 2431 and S2500: Mental Health Professionals Workforce Shortage Loan Repayment Act. Authorizes a loan repayment program for mental health professionals to relieve workforce shortages Bill #H.R. 2482 and S2074: Mainstreaming Addiction Treatment (MAT) Act. Loosens restrictions on doctors prescribing buprenorphine for addiction treatment Bill #H.R. 2895 and S948: Conrad State 30 and Physician Access Reauthorization Act. Reauthorizes the Conrad 30 program through FY 2021 Bill #H.R. 3165 and S1737: Mental Health Parity Compliance Act. To achieve complete implementation of the Mental Health Parity and Addiction Equity Act (federal parity law) Bill #H.R. 4004 and S2986: Social Determinants Accelerator Act. To direct the Secretary of Health and Human Services to establish an interagency council on social determinants of health Bill #H.R. 4468: Nursing Home Workforce Quality Act. To address the shortage of certified nursing assistants (CNAs) Bill #H.R. 4859: Protecting Older Americans from Social Isolation Act. To amend the Older Americans Act to reduce social isolation among older individuals Bill #H.R. 5242: Opioid Settlement Accountability Act. To ensure that opioid settlement funds are used to fight the opioid epidemic, including treatment, prevention, education and enforcement efforts. Bill # H.R. 945 and S286: Mental Health Access Improvement Act. To provide for the coverage of marriage and family therapist services and mental health counselor services under Medicare Bill # H.R. 986:Protecting Americans with Preexisting Conditions Act.To prevent the promotion of short-term, limited duration insurance plans and association health plans Bill #S1399:Title VIII Nursing Workforce Reauthorization Act.To amend title VIII of the Public Health Service Act to extend advanced education nursing grants to support clinical nurse specialist programs Bill #S1895 Lower Health Care Costs Act Bill # HR5640 and S3152:Data Mapping to Save Moms' Lives Act. To require the Federal Communications Commission to incorporate data on maternal health outcomes into its broadband health maps. Bill # S3374: Protecting Jessica Grubbs Legacy Act. Amends the Public Health Service Act to protect the confidentiality of substance use disorder patient records. Bill S3599 and HR6788 Healthcare Workforce Resilience Act to expand the number of immigrant visas available to nurses and physicians Bill # HR748 S3548: Coronavirus Aid, Relief, and Economic Security Act provides financial relief and resources to individuals, families, and businesses impacted by the COVID-19 public health emergency. Bill # 7010 Paycheck protection program flexibility Bill #HR7292 Advanced Accelerated Payment Program forgiveness Bill HR 7077 and S3877 Community Solutions for COVID-19 Act grants to reduce or eliminate disparities HR 8200 Ending health disparities during COVID-19 Bill HR7838 and S4160 To enable certain hospitals participating in 340B drug discount program prior to COVID-19 public health emergency to maintain eligibility
| Democratic |
| MA |
| John Boozman | Republican | AR |
| Kirsten E. Gillibrand | Democratic | NY |
| Rob Portman | Republican | OH |
| Shelley Moore Capito | Republican | WV |
| Sherrod Brown | Democratic | OH |
| Susan M. Collins | Republican | ME |
| Tammy Baldwin | Democratic | WI |
| Tom Cotton | Republican | AR |
Client expense: $1,035,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Citizenship & Immigration Services (BCIS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Natl Science Foundation (NSF), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Science & Technology Policy (OSTP), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Substance Abuse & Mental Health Services Administration (SAMHSA), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
Client expense: $370,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Client expense: $210,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Navy, Dept of, SENATE
2020 · fourth_quarter · Health Issues
Healthcare and COVID-19 measures included in the Consolidated Appropriations Act of 2020 (H.R. 133) Public Health and Social Services Emergency Fund (coronavirus relief packages-H.R. 6201, H.R. 748, H.R. 7010, H.R. 6800, H.R. 6800, HEALS Act, S. 4775, H.R. 133) Provider Relief Fund Reporting Requirements Regulatory relief in light of coronavirus (all coronavirus relief packages - H.R. 6074, H.R. 6201, H.R. 748, H.R. 7010, H.R. 6800, H.R. 6800, HEALS Act, S. 4775, H.R. 133) Healthcare Workforce Resilience Act (S. 3599/H.R. 6788) Hospital Price Transparency (surprise medical bills; public posting of hospital charges; Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First; Final Rule on Price Transparency; Transparency in Coverage Proposed Rule; inpatient prospective payment system rule) Surprise Medical Bills (H.R. 133; H.R. 5826; H.R. 3630; S. 1531) Liability relief (S. 4317; all coronavirus relief packages - H.R. 6074, H.R. 6201, H.R. 748, H.R. 7010, H.R. 6800; H.R. 6800, HEALS Act, S. 4775, H.R. 133) H.R. 7538, Essential Workforce Parity Act (providing liability relief and amending FMLA leave provisions) S. 3763 / H.R. 6953, Pandemic Responder Service Award Act Hospital preparedness program (H.R. 6074) 340B Drug Pricing Program (S. 4160) Public Health Emergency designation Vaccine distribution Maternal Mortality (S. 4949, Supporting Best Practices for Healthy Moms Act)
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
(S. 3595/H.R. 6701) - Ensuring Understanding of Covid-19 to Protect Public Health Act - Expressed support for the Ensuring Understanding of Covid-19 to Protect Public Health Act. This legislation would authorize a longitudinal study of a diverse set of covid-19 patients to ensure that we are able to gain a full understanding of the disease, including long-term health impacts and the best options for treating it. Such an understanding will be essential to ensuring that health providers such as ours are able to best meet the needs of covid-19 survivors in the future. Urged the Senate to support S. 4160 - A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes. Urged the House to support H.R. 2271, the Scarlett's Sunshine on Sudden Unexpected Death Act which would strengthen existing efforts to better understand Sudden Unexplained Death in Childhood (SUDC) and Sudden Unexpected Infant Death (SUID), facilitate data collection and analysis to improve prevention efforts, and support children and families. Urged the House to support H.R. 2468, the School-Based Allergies and Asthma Management Program Act which would encourage schools receiving asthma-related grants to have trained personnel and a comprehensive school-based allergies and asthma management program. Urged the House to support H.R. 7539, the Strengthening Behavioral Parity Act contains numerous provisions to improve existing law, most notable prohibiting health insurance plans from imposing less favorable benefit limitations on mental and substance use disorder treatments than on medical and surgical benefits. Urged the House to support H.R. 1646, the Helping Emergency Responders Overcome (HERO) Act of 2019 which would support the mental health of our first responders by authorizing grants for peer support behavioral health and wellness programs within fire departments and emergency medical service agencies. Urged the House to support H.R. 4564, the Suicide Prevention Lifeline Improvement Act of 2019 which would significantly increase the funding levels for the National Suicide Prevention Lifeline while also directing HHS to conduct research and analysis on best practices to ensure continued success of the program. Urged the House to support H.R. 4585, the Campaign to Prevent Suicide Act whick would direct HHS, in coordination with Centers for Disease Control and Prevention (CDC) and the Substance Abuse and Mental Health Services Administration (SAMHSA), to carry out a national suicide prevention media campaign to advertise the new 9-8-8 number, when it becomes effective, raise awareness for suicide prevention resources, and cultivate a more effective discourse on how to prevent suicide. Urged the House to support H.R. 5619, the Suicide Prevention Act which would establish grant programs at the CDC and SAMHSA to prevent self-harm and suicide to be awarded to public health departments and to hospital emergency departments. Urged the House to support H.R. 4194, the National Suicide Hotline Designation Act of 2019 which amends the Communications Act to designate 9-8-8 as the universal dialing code for the National Suicide Prevention Lifeline. (S. 3721/ H.R. 6763) COVID-19 Racial and Ethnic Disparities Task Force Act - Expressed support for the COVID-19 Racial and Ethnic Disparities Task Force Act. This legislation would address the health disparities faced by minority communities during the pandemic and would establish a permanent Infectious Disease Racial Disparities task force to ensure that in future pandemics, our health care system and emergency response addresses the issues of racial and ethnic health disparities. (H.R. 6638) Reducing COVID-19 Disparities by Investing in Public Health Act - Expressed support for the Reducing COVID-19 Disparities by Investing in Public Health Act. This legislation would increase the annual funding for the Chronic Disease Prevention and Health Promotion Fund, the National Institute on Minority Health and Health Disparities, and the various offices of Minority Health within the Office of the Secretary of HHS, the Agency for Healthcare Research and Quality, the Centers for Disease Control and Prevention, the Centers for Medicare & Medicaid Services, the Food and Drug Administration, the Health Resources and Services Administration, and the Substance Abuse and Mental Health Services Administration. These agencies play a major role in understanding racial and ethnic health disparities, while also engaging in policy solutions towards their elimination. (H.R 1425) Patient Protection and Affordable Care Enhancement Act - Urged House to vote for passage of this bill. This legislation provides several necessary additions and improvements to the landmark Affordable Care Act (ACA), ensuring that accessible and affordable care is available for all those who need it in our country. Senate Committee on Finance requested information and solutions for improving maternal health. Responded to the committee with ways to identify and implement high-quality and effective health care services and gave a specific example of a tool developed by a CHA member. Coronavirus Immigrant Families Protection Act (H.R. 6437) - Supports modifying immigration policies that would deter immigrants from seeking health services for the duration of the coronavirus emergency and for 60 days after the emergency ends, ensure that everyone has access to covid-19 testing, treatment, and vaccines, and provide $100 million for the Centers for Disease Control and Prevention to provide language access and public outreach. Improve Childrens Access to Care: Increase Funding for the Childrens Hospitals Graduate Medical Education (CHGME) Program - Requested Congress support for childrens health and provide $465 million in funding for CHGME for FY 2021. Urged the House to support H.R. 3398, the Pathways to Health Careers Act of 2019, which includes legislation that extends the current Health Profession Opportunity Grant (HPOG) demonstration grants and aims to increase the pipeline of the health care workforce, including in rural areas and the territories. No Surprises Act (H.R. 3630) - Opposed the establishment of a statutory payment rate. Palliative Care and Hospice Education and Training Act (H.R. 647, S.2080) - Urged Congress to support palliative care education for medical providers and reduce barriers to care for patients with serious or life-threatening illnesses. Protecting Americans with Pre-existing Conditions Act (H.R. 986) - Supported affordable health care coverage and consumer protections for patients with pre-existing conditions. Health Care Affordability Act of 2019 (H.R. 1868) - Supported reducing insurance premiums and out-of-pocket costs in the insurance marketplace for low-income families not eligible for tax credits. Strengthening Health Care and Lowering Prescription Drug Costs Act (H.R. 987) - Supported lowering prescription drug costs and strengthening the Affordable Care Act exchange market. Overdose Prevention and Safety Act (H.R. 2062) - Supported the alignment of substance use disorder health records with HIPAA protections. Supported the 340B outpatient drug pricing program for safety net hospitals. Lower Health Care Costs Act (S. 1895) - Opposed the proposed bill amendment which would reduce the scope and effectiveness of the 340B outpatient drug pricing program. Supported protection against surprise medical bills. Opposed a statue payment rate. The Resident Physician Shortage Reduction Act of 2019 (H.R. 1763, S. 348) - Supported increased physician training in geriatric care and telemedicine to improve patient health care access.
Client expense: $196,341 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Natl Institutes of Health (NIH), Office of the Vice President of the United States, President of the U.S., SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of
2020 · fourth_quarter · Medicare/Medicaid
General issues relating to Medicare, Medicaid, disproportionate share hospital payment, 340B, and COVID-19 relief. H.R. 4538 - Closing Loopholes for Orphan Drugs Act S. 4160, H.R. 7838 H.R. 8337 - Continuing Appropriations Act, 2021 and Other Extensions Act H.R. 133 - Consolidated Appropriations Act, 2021
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
General issues relating to Medicare, Medicaid, disproportionate share hospital payment, 340B, and COVID-19 relief. H.R. 4538 - Closing Loopholes for Orphan Drugs Act S. 4160, H.R. 7838 H.R. 8337 - Continuing Appropriations Act, 2021 and Other Extensions Act H.R. 133 - Consolidated Appropriations Act, 2021
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Health Issues
Issues relating to the 340B drug pricing program. H.R. 4538 - Closing Loopholes for Orphan Drugs Act S. 4160, H.R. 7838 H.R. 8337 - Continuing Appropriations Act, 2021 and Other Extensions Act H.R. 133 - Consolidated Appropriations Act, 2021
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Medicare/Medicaid
Issues relating to the 340B drug pricing program. H.R. 4538 - Closing Loopholes for Orphan Drugs Act S. 4160, H.R. 7838 H.R. 8337 - Continuing Appropriations Act, 2021 and Other Extensions Act H.R. 133 - Consolidated Appropriations Act, 2021
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Medicare/Medicaid
340B Drug Discount Program H.R. 1763, S. 348 - Resident Physician Shortage Reduction Act Graduate Medical Education Disproportionate Share Hospital payments Childrens Health Insurance Program Medicare Dependent Hospital Program (MDH) Medicaid Low Volume Payments (LV) Federal Medical Assistance Percentage Extension Inpatient Prospective Payment System Outpatient Prospective Payment System Bad debt/charity care Hospital Outpatient Department payments H.R. 2439, S. 2892 - Opioid Workforce Act H.R. 1358 - Advancing Medical Resident Training in Community Hospitals Act of 2019 S. 4160 - To maintain hospital 340B eligibility during the COVID-19 public health emergency S. 4160, H.R. 7838 - 340B Pandemic Eligibility Waiver bill CMS Accelerated and Advanced Payments COVID-19 Relief
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Pharmacy
The 340B Drug Pricing Program; FY 2021 L-HHS Appropriations; H.R. 133: Consolidated Appropriations Act, 2021; H.R. 4538, Closing Loopholes for Orphan Drug Act; S. 4160, A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes; H.R. 7838, To provide for certain temporary waivers with respect to the 340B drug discount program due to the COVID-19 public health emergency, and for other purposes; S.4796, Fair Care Act of 2020; H.R.8527, Fair Care Act of 2020
Client expense: $259,229 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE
2020 · third_quarter · Pharmacy
S 4160 and HR 7838 340B Enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the public health service act prior to the COVID-19 public health emergency to temporarily maintain eligibility for program
Client expense: $200,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Navy, Dept of, SENATE
2020 · third_quarter · Health Issues
Bill # H.R. 647 and S2080: Palliative Care and Hospice Education and Training Act. Establishes Palliative Care and Hospice Education Centers to increase access to palliative care Bill # H.R. 728: Title VIII Nursing Workforce Reauthorization Act.To amend title VIII of the Public Health Service Act to extend advanced education nursing grants to support clinical nurse specialist programs Bill # H.R. 1767 and S824: Excellence in Mental Health and Addiction Treatment Expansion Act. To increase the number of states that may conduct Medicaid demonstration programs to improve access to community mental health services Bill # H.R. 2062 and S1012: Overdose Prevention and Patient Safety Act.Amends the Public Health Service Act to protect the confidentiality of substance use disorder patient records Bill # H.R. 2431 and S2500: Mental Health Professionals Workforce Shortage Loan Repayment Act. Authorizes a loan repayment program for mental health professionals to relieve workforce shortages Bill #H.R. 2482 and S2074: Mainstreaming Addiction Treatment (MAT) Act. Loosens restrictions on doctors prescribing buprenorphine for addiction treatment Bill #H.R. 2895 and S948: Conrad State 30 and Physician Access Reauthorization Act. Reauthorizes the Conrad 30 program through FY 2021 Bill #H.R. 3165 and S1737: Mental Health Parity Compliance Act. To achieve complete implementation of the Mental Health Parity and Addiction Equity Act (federal parity law) Bill #H.R. 4004 and S2986: Social Determinants Accelerator Act. To direct the Secretary of Health and Human Services to establish an interagency council on social determinants of health Bill #H.R. 4468: Nursing Home Workforce Quality Act. To address the shortage of certified nursing assistants (CNAs) Bill #H.R. 4859: Protecting Older Americans from Social Isolation Act. To amend the Older Americans Act to reduce social isolation among older individuals Bill #H.R. 5242: Opioid Settlement Accountability Act. To ensure that opioid settlement funds are used to fight the opioid epidemic, including treatment, prevention, education and enforcement efforts. Bill # H.R. 945 and S286: Mental Health Access Improvement Act. To provide for the coverage of marriage and family therapist services and mental health counselor services under Medicare Bill # H.R. 986:Protecting Americans with Preexisting Conditions Act.To prevent the promotion of short-term, limited duration insurance plans and association health plans Bill #S1399:Title VIII Nursing Workforce Reauthorization Act.To amend title VIII of the Public Health Service Act to extend advanced education nursing grants to support clinical nurse specialist programs Bill #S1895 Lower Health Care Costs Act Bill # HR5640 and S3152:Data Mapping to Save Moms' Lives Act. To require the Federal Communications Commission to incorporate data on maternal health outcomes into its broadband health maps. Bill # S3374: Protecting Jessica Grubbs Legacy Act. Amends the Public Health Service Act to protect the confidentiality of substance use disorder patient records. Bill S3599 and HR6788 Healthcare Workforce Resilience Act to expand the number of immigrant visas available to nurses and physicians Bill # HR748 S3548: Coronavirus Aid, Relief, and Economic Security Act provides financial relief and resources to individuals, families, and businesses impacted by the COVID-19 public health emergency. Bill # 7010 Paycheck protection program flexibility Bill #HR7292 Advanced Accelerated Payment Program forgiveness Bill HR 7077 and S3877 Community Solutions for COVID-19 Act grants to reduce or eliminate disparities HR 8200 Ending health disparities during COVID-19 Bill HR7838 and S4160 To enable certain hospitals participating in 340B drug discount program prior to COVID-19 public health emergency to maintain eligibility
Client expense: $200,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Navy, Dept of, SENATE
2020 · third_quarter · Health Issues
Issue: Educate Congress and the administration on academic medicines missions, including education, research, patient care, GME, workforce, and physician shortages in rural and urban communities. H.R. 6650, S. 3634, Health Heroes 2020 Act S. 4055, Strengthening Americas Health Care Readiness Act Issue: Support increased funding for the National Health Service Corps, and National Disaster Medical Service (NDMS) demonstration pilot. Issues: Educate Congress and the administration about academic medicines response to the opioid epidemic. Support funding for training on substance use disorders, pain management, and safe prescribing practices. Support suspension of DATA waivers. Support continuation of telehealth flexibilities allowing authorized practitioners to prescribe buprenorphine. P.L. 116-22, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 Issues: Support the Hospital Preparedness Program and the reauthorization of the Pandemic and All-Hazards Preparedness Act. Support increased funding authorization levels. Issue: Oppose burdensome regulation of Laboratory Developed Tests Issues: Support high-quality affordable health insurance. Support programs and funds for safety-net providers. Issue: Support measures to preserve and strengthen the 340B Drug Pricing Program and oppose efforts to reduce the scope of the program, including instituting a moratorium, increasing reporting requirements on covered entities, and imposing user fees S. 1895, Lower Health Care Costs Act H.R. 3630, No Surprises Act S. 1531, Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 H.R. 3502, Protecting People From Surprise Medical Bills Act Issues: Educate Congress on surprise medical bills and price disclosure. Support general principles for surprise medical bills draft legislation. Oppose statutory benchmark rate setting. Oppose Senate hospital/insurer contracting provisions and onerous reporting burden. S. 1895, Lower Health Care Costs Act, Title IV Issues: Prescription drug pricing, public health, maternal mortality, and health information technology. Issue: Support legislation providing stable and predictable funding for quality measurement activities carried out by the National Quality Forum Issue: Development of Enhanced Primary Care Pilot Act proposal Issue: Educate Congress about medical education on nutrition, consent, implicit bias, and maternal health. Issue: Oppose restrictions on diversity training for federal grantees and employees. Issue: Educate Congress on the structural racism and inherent biases that have created health inequities that impact minority communities and other marginalized groups, including the disproportionate impact of COVID-19 on communities of color. Issue: Support public health guidance for law enforcement regarding tactics to reduce the risk of coronavirus transmission, and to protect all personal and health data collected as part of the COVID-19 response. Issue: Support initiatives of hospitals to promote affordable housing in local communities and eliminate other social determinants of health to improve health equity. H.R. 6637, Health Equity and Accountability Act Issue: Support programs to improve health equity and address social determinants of health. H.R. 4004, S. 2986 Social Determinants Accelerator Act of 2019 Issue: Support grants to address social determinants of health Issue: Support congressional investment in the Centers for Medicare and Medicaid Innovation (CMMI) models to reduce maternal mortality and improve maternal health. S. 3750/H.R. 6837, Medicare Accelerated and Advance Payment Improvement Act of 2020 Issue: Support improvements to the Medicare Accelerated and Advance Payment Programs. Draft, firearm safety legislation Issue: Support universal background checks, violence prevention programs, extreme risks protection orders, child access safety laws, and reinstating assault weapons ban. H.R. 8, Bipartisan Background Checks Act of 2019 Issue: Support universal background checks Issue: Support aligning 42 CFR Part 2 regulations with the Health Insurance Portability and Accountability Act (HIPAA) for the purposes of treatment, payment, and healthcare operations. S. 4349/H.R. 8094, Dr. Lorna Breen Health Care Provider Protection Act Issue: Support grants directed at improving physician burnout and well-being. P.L. 116-123, Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020 P.L. 116-127, Families First Coronavirus Response Act P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES) Act H.R.6379, Take Responsibility for Workers and Families Act H.R. 6800, the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act Draft Health, Economic Assistance, Liability Protection and Schools (HEALS) Act S. 178 with Amendment No. 2652 HEALS Act S. 4322, Safely Back to School and Back to Work Act S. 178, Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act H.R. 8406, The Heroes Act Issues: Support emergency supplemental funding and policies for federal agencies to support coronavirus preparedness, response, relief, and testing. Ensure access to research samples. Support funding for and provide recommendations for disbursement of provider relief fund. Support revised Medicare and Medicaid reimbursement policies and increased provider flexibility. Support improvements to the Medicare Accelerated and Advance Payment Programs. Support inclusion of Medicare-supported graduate medical education positions. Support an increase in the Federal Medicaid Assistance Program. Support for current telehealth waivers to be made permanent. Provide recommendations on personal protective equipment, testing, social distancing, clinical care, and other COVID related preparedness and response efforts of the federal government. Avoid imposing standards that would encourage depletion of scarce PPE and other resources. Support enhanced national COVID-19 data collection to better address health disparities. See other additions under BUD. Issue: Support extension of public health emergency declaration. Issue: Provide feedback on COVID-19 and pandemic response centers of excellence legislation. Issue: Urge establishment and implementation of robust national COVID-19 testing strategy and functional and transparent supply chain. Urge CDC to update testing guidelines. Issue: Describe medical education approach on womens health and support efforts to promote trauma-informed care. Issue: Support science and data driven approach to HHS decision making. Issue: Support CDC mission S 4248, HR 7618, COVID-19 Bias and Anti-Racism Training Act Issue: Support grant for anti-racism training in health professions programs. H.R. 8017, Mobile Options for Testing In Our Neighborhoods (MOTION) Act Issue: Support grants for mobile COVID-testing units. S. 4160, To enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes. Issue: Support protections for hospitals that participate in the 340B Drug Pricing Program to temporarily allow them to remain eligible for the program. H.R. 8283 S. 4421, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act Issue: Support for a temporary uniform licensing standard for all practitioners in all states throughout a national emergency.
Client expense: $1,095,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Bureau of Citizenship & Immigration Services (BCIS), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Natl Science Foundation (NSF), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Science & Technology Policy (OSTP), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Substance Abuse & Mental Health Services Administration (SAMHSA), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
2020 · third_quarter · Medicare/Medicaid
340B Drug Discount Program H.R. 1763, S. 348 - Resident Physician Shortage Reduction Act Graduate Medical Education Disproportionate Share Hospital payments Childrens Health Insurance Program Medicare Dependent Hospital Program (MDH) Medicaid Low Volume Payments (LV) Federal Medical Assistance Percentage Extension Inpatient Prospective Payment System Outpatient Prospective Payment System Bad debt/charity care Hospital Outpatient Department payments H.R. 2439, S. 2892 - Opioid Workforce Act H.R. 1358 - Advancing Medical Resident Training in Community Hospitals Act of 2019 S. 4160 - To maintain hospital 340B eligibility during the COVID-19 public health emergency S. 4160, H.R. 7838 - 340B Pandemic Eligibility Waiver bill
Client expense: $90,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Health Issues
The Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074) Families First Coronavirus Response Act (H.R. 6201) The Coronavirus Aid, Relief, and Economic Security Act (H.R. 748, S. 3548) Paycheck Protection Program Flexibility Act of 2020 (H.R. 7010) Health and Economic Recovery Omnibus Emergency Solutions Act (H.R. 6800) HEALS Act; S. 4775, Delivering Immediate Relief to America's Families, Schools and Small Businesses Act Public Health and Social Services Emergency Fund (coronavirus relief packages-H.R. 6201, H.R. 748, H.R. 7010, H.R. 6800, H.R. 6800, HEALS Act, S. 4775) Provider Relief Fund Reporting Requirements Regulatory relief in light of coronavirus (all coronavirus relief packages - H.R. 6074, H.R. 6201, H.R. 748, H.R. 7010, H.R. 6800, H.R. 6800, HEALS Act, S. 4775) Healthcare Workforce Resilience Act (S. 3599/H.R. 6788) Hospital Price Transparency (surprise medical bills; public posting of hospital charges; Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First; Final Rule on Price Transparency; Transparency in Coverage Proposed Rule; inpatient prospective payment system rule) Surprise Medical Bills Liability relief (S. 4317; all coronavirus relief packages - H.R. 6074, H.R. 6201, H.R. 748, H.R. 7010, H.R. 6800; H.R. 6800, HEALS Act, S. 4775) H.R. 7538, Essential Workforce Parity Act (providing liability relief and amending FMLA leave provisions) S. 3763 / H.R. 6953, Pandemic Responder Service Award Act Hospital preparedness program (H.R. 6074) 340B Drug Pricing Program (S. 4160) Drug pricing policy and drug shortages Public Health Emergency designation Vaccine distribution planning
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Health Issues
P.L. 116-136, Coronavirus Aid, Relief, and Economic Security (CARES) Act - provisions related to infusion issues for Medicare patients, amendments to the Tax Cuts and Jobs Act (TCJA) and the orphan drug tax credit; Issues related to the use of plasma therapies in COVID-19 patients; Communications with DFC regarding Project Warp Speed - provisions related to use of plasma to treat COVID-19; H.R. 1425, The Patient Protection and Affordable Care Enhancement Act Discussions to clarify or reform the 340B program; S.4160 - A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes - provisions to clarify or reform the 340B program; Discussions on value-based drug contracting; Proposals related to drug pricing, including House and Senate draft bills; H.R. 1035; Prescription Drug Price Transparency Act - provisions related to drug pricing transparency and pharmacy benefit managers; S. 378, H.R. 1093, The Stop Price Gouging Act - provisions related to prescription drug pricing; Discussions related to co-pay accumulators; S. 657, Drug Price Transparency Act - provisions related to prescription drug pricing transparency and commercial market rebates; H.R. 2279, S. 2546, Safe Step Act - provisions related to step therapy policy; H.R. 3276, S. 1785, Fair AMP Act - provisions related to AMP cap, exclusion of authorized generics from AMP; H.R. 3, Lower Drug Costs Now Act of 2019 - provisions related to the establishment of programs and requirements relating to the prices of prescription drugs; H.R. 19, Lower Costs, More Cures Act of 2019 - provisions related to AMP cap removal, Medicare Part D redesign, exclusivity periods, vial wastage, drug price transparency, add-on payment and pay-fors; VA MISSION Act of 2018 (P.L. 115 - 182) - provisions related to healthcare coverage after dischange from active duty; H.R. 5201, Telemental Health Expansion Act of 2019 - provisions related to mental telehealth coverage; Issues related to global pharmaceutical supply chain operations and manufacturing locations; H.R. 2507, S. 2158, Newborn Screening Saves Lives Reauthorization of 2019 - provisions related to newborn screening; H.R. 6800, The Heroes Act - provisions related to tax issues and plasma treatments; Discussions related to Most Favored Nation/International Reference Pricing including the Executive Order; E.O. 13937, Access to Affordable Life-Saving Medications; E.O. 13938, Increasing Drug Importation to Lower Prices for American Patients; E.O. 13939, Lowering Drug Prices by Eliminating Kickbacks to Middlemen; E.O. 13947, 13948, Lowering Drug Prices by Putting America First; E.O. 13944, Combating Public Health Emergencies and Strengthening National Security by Ensuring Essential Medicines, Medical Countermeasures, and Critical Inputs are Made in the United States; E.O. 13951, An America-First Healthcare Plan; E.O 13950, Combating Race and Sex Stereotyping.
Client expense: $1,160,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2020 · third_quarter · Health Issues
Urged the Senate to support S. 4160 - A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes. Urged the House to support H.R. 2271, the Scarlett's Sunshine on Sudden Unexpected Death Act which would strengthen existing efforts to better understand Sudden Unexplained Death in Childhood (SUDC) and Sudden Unexpected Infant Death (SUID), facilitate data collection and analysis to improve prevention efforts, and support children and families. Urged the House to support H.R. 2468, the School-Based Allergies and Asthma Management Program Act which would encourage schools receiving asthma-related grants to have trained personnel and a comprehensive school-based allergies and asthma management program. Urged the House to support H.R. 7539, the Strengthening Behavioral Parity Act contains numerous provisions to improve existing law, most notable prohibiting health insurance plans from imposing less favorable benefit limitations on mental and substance use disorder treatments than on medical and surgical benefits. Urged the House to support H.R. 1646, the Helping Emergency Responders Overcome (HERO) Act of 2019 which would support the mental health of our first responders by authorizing grants for peer support behavioral health and wellness programs within fire departments and emergency medical service agencies. Urged the House to support H.R. 4564, the Suicide Prevention Lifeline Improvement Act of 2019 which would significantly increase the funding levels for the National Suicide Prevention Lifeline while also directing HHS to conduct research and analysis on best practices to ensure continued success of the program. Urged the House to support H.R. 4585, the Campaign to Prevent Suicide Act whick would direct HHS, in coordination with Centers for Disease Control and Prevention (CDC) and the Substance Abuse and Mental Health Services Administration (SAMHSA), to carry out a national suicide prevention media campaign to advertise the new 9-8-8 number, when it becomes effective, raise awareness for suicide prevention resources, and cultivate a more effective discourse on how to prevent suicide. Urged the House to support H.R. 5619, the Suicide Prevention Act which would establish grant programs at the CDC and SAMHSA to prevent self-harm and suicide to be awarded to public health departments and to hospital emergency departments. Urged the House to support H.R. 4194, the National Suicide Hotline Designation Act of 2019 which amends the Communications Act to designate 9-8-8 as the universal dialing code for the National Suicide Prevention Lifeline. (S. 3721/ H.R. 6763) COVID-19 Racial and Ethnic Disparities Task Force Act - Expressed support for the COVID-19 Racial and Ethnic Disparities Task Force Act. This legislation would address the health disparities faced by minority communities during the pandemic and would establish a permanent Infectious Disease Racial Disparities task force to ensure that in future pandemics, our health care system and emergency response addresses the issues of racial and ethnic health disparities. (H.R. 6638) Reducing COVID-19 Disparities by Investing in Public Health Act - Expressed support for the Reducing COVID-19 Disparities by Investing in Public Health Act. This legislation would increase the annual funding for the Chronic Disease Prevention and Health Promotion Fund, the National Institute on Minority Health and Health Disparities, and the various offices of Minority Health within the Office of the Secretary of HHS, the Agency for Healthcare Research and Quality, the Centers for Disease Control and Prevention, the Centers for Medicare & Medicaid Services, the Food and Drug Administration, the Health Resources and Services Administration, and the Substance Abuse and Mental Health Services Administration. These agencies play a major role in understanding racial and ethnic health disparities, while also engaging in policy solutions towards their elimination. (H.R 1425) Patient Protection and Affordable Care Enhancement Act - Urged House to vote for passage of this bill. This legislation provides several necessary additions and improvements to the landmark Affordable Care Act (ACA), ensuring that accessible and affordable care is available for all those who need it in our country. Senate Committee on Finance requested information and solutions for improving maternal health. Responded to the committee with ways to identify and implement high-quality and effective health care services and gave a specific example of a tool developed by a CHA member. Coronavirus Immigrant Families Protection Act (H.R. 6437) - Supports modifying immigration policies that would deter immigrants from seeking health services for the duration of the coronavirus emergency and for 60 days after the emergency ends, ensure that everyone has access to covid-19 testing, treatment, and vaccines, and provide $100 million for the Centers for Disease Control and Prevention to provide language access and public outreach. Improve Childrens Access to Care: Increase Funding for the Childrens Hospitals Graduate Medical Education (CHGME) Program - Requested Congress support for childrens health and provide $465 million in funding for CHGME for FY 2021. Urged the House to support H.R. 3398, the Pathways to Health Careers Act of 2019, which includes legislation that extends the current Health Profession Opportunity Grant (HPOG) demonstration grants and aims to increase the pipeline of the health care workforce, including in rural areas and the territories. No Surprises Act (H.R. 3630) - Opposed the establishment of a statutory payment rate. Palliative Care and Hospice Education and Training Act (H.R. 647, S.2080) - Urged Congress to support palliative care education for medical providers and reduce barriers to care for patients with serious or life-threatening illnesses. Protecting Americans with Pre-existing Conditions Act (H.R. 986) - Supported affordable health care coverage and consumer protections for patients with pre-existing conditions. Health Care Affordability Act of 2019 (H.R. 1868) - Supported reducing insurance premiums and out-of-pocket costs in the insurance marketplace for low-income families not eligible for tax credits. Strengthening Health Care and Lowering Prescription Drug Costs Act (H.R. 987) - Supported lowering prescription drug costs and strengthening the Affordable Care Act exchange market. Overdose Prevention and Safety Act (H.R. 2062) - Supported the alignment of substance use disorder health records with HIPAA protections. Supported the 340B outpatient drug pricing program for safety net hospitals. Lower Health Care Costs Act (S. 1895) - Opposed the proposed bill amendment which would reduce the scope and effectiveness of the 340B outpatient drug pricing program. Supported protection against surprise medical bills. Opposed a statue payment rate. The Resident Physician Shortage Reduction Act of 2019 (H.R. 1763, S. 348) - Supported increased physician training in geriatric care and telemedicine to improve patient health care access.
Client expense: $181,961 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Natl Institutes of Health (NIH), Office of the Vice President of the United States, President of the U.S., SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of
2020 · third_quarter · Health Issues
HEROES Act H.R. 6800/COVID 4 Supplemental- provisions related to funding relief for hospitals and healthcare providers; Issues related to COVID-19 pandemic response for healthcare providers and hospitals S. 4160 - provisions related to section 340B of the Public Health Service Act H.R.6788; S.3599 Healthcare Workforce Resilience Act - provisions on the allocation of unused visas for healthcare professionals
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Health Issues
COVID-19 crisis - Engaged with Congress and the administration to advocate for greater regulatory flexibility and appropriate reimbursement for hospitals through development, passage and ongoing implementation of coronavirus relief legislation: HEROES Act (H.R. 6800) Heroes Act 2.0 (H.R. 925) Health, Economic Assistance, Liability Protection and Schools (HEALS) Act S. 178 Hospital Provider Relief Fund - Urged Congress to increase funding available for the Provider Relief Fund and maintain established guidelines. Liability protections - Advocated for Congress to include liability protections for health care workers and facilities responding to the COVID-19 crisis. Front-line Health Care Worker Hazard Pay - Advocated for Congress to provide funding to enhance payment for essential health care workers. Hospital Group Purchasing - Offered recommendations and insights to support access to essential personal protective equipment, medications and supplies for hospitals treating patients and supply chain stability for the national response to the COVID-19 crisis. Prescription Drug Safety - Supported passage of the Safe Drugs Act (S. 4492) 340B Drug Pricing Program - Supported legislation to ensure hospitals eligible for the 340B Drug Pricing Program do not lose eligibility due to changing patient mix during the COVID-19 crisis. Advocated for preserving the current structure of the program (S. 4160). Urged HHS to act to enforce guidance regarding 340B discounts through contract pharmacies. Surprise Billing - Supported inclusion of provisions to provide for an independent dispute resolution process in legislation to address surprise bills (H.R. 3630; H.R. 2328; S. 1895). Urged Congress to oppose benchmark payment rates in COVID relief legislation. Stark and Antikickback Statute - Uged the administration to finalize regulations that offer new flexibilty for Stark and Antikickback Statute regulations for value-based arrangements.
Client expense: $210,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, Treasury, Dept of
2020 · third_quarter · Health Issues
Repeal of the Affordable Care Act Development of legislation to protect essential hospitals Issues related to telehealth Mental Health Essential Health Benefits created by the Affordable Care Act Access to hospital emergency services Issues related to the 340B Drug Pricing Program 340B dug pricing program CMS OPPS 340B rule moratorium-related legislation 42 CFR Part 2 CREATES Act-H.R.965 Cassidy Surprise Billing Draft Protecting Patients from Surprise Medical Bills Excellence in Metal Health Act (S.824/H.R.1767) Patient Centered Outcomes Research Institute Funding No Surprises Act Lower Health Care Costs Act Surprise Medical Bills H.R.4004 - Social Determinants Accelerator Act of 2019 S.2986 - Social Determinants Accelerator Act of 2019 H.R.2328 - Reauthorizing and Extending America's Community Health Act S.2723 - Mitigating Emergency Drug Shortages Act H.R.4995 - Maternal Health Quality Improvement Act of 2019 H.R.2889 - Closing Loopholes for Orphan Drugs Act 340B drug pricing program eligibility (Matsui-Stewart Dear Colleague letter) Relief for Rural Providers During Emergencies Act (S. 3631) Improving Social Determinants of Health Act (H.R. 6561) Liability reform Issues related to COVID-19 regulatory and financial relief COVID-19 Provider Relief Fund Resolution recognizing racism as public health issue - S. Res. 655 COVID-19 Bias and Anti-Racism Training Act - S. 4248 Protecting 340B eligibility during the pandemic - S. 4160 and HR 7838 Protect Telehealth Access Act of 2020 (HR 7391) Improving Social Determinants of Health Act - S. 4440 Maternal health 340B contract pharmacies (McKinley-DeGette-Gianforte-Matsui-Johnson-Welch Dear Colleague letter) 340B contract pharmacies (Baldwin-Capito-Cardin-Portman-Stabenow-Thune Dear Colleague letter) Delivering Immediate Relief to Americas Families, Schools and Small Businesses Act Health disparities COVID-19 payroll tax credits
Client expense: $290,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2020 · third_quarter · Pharmacy
The 340B Drug Pricing Program; FY 2021 L-HHS Appropriations; H.R. 4538, Closing Loopholes for Orphan Drug Act; S. 3631, Relief for Rural Providers During Emergencies Act; S. 4160, A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes; S. 4199, A bill to amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes; H.R. 7838, To provide for certain temporary waivers with respect to the 340B drug discount program due to the COVID-19 public health emergency, and for other purposes.
Client expense: $267,118 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2020 · third_quarter · Health Issues
To Address Pharmacy DIR fees in next CoVid19 package. H.R.1034/S.640, The Phair Pricing Act of 2019 H.R. 7838- To provide for certain temporary waivers with respect to the 340B drug discount program due to COVID-19 public health emergency, and for other purposes. S.4160- A bill to enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the Public Health Service Act prior to the COVID-19 public health emergency to temporarily maintain eligibility for such program, and for other purposes. S.2543 Grassley/Wyden's Prescription Drug Pricing Reduction Act of 2019 Executive Order on insulin and Epi-Pen
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Vice President of the U.S.
2020 · third_quarter · Health Issues
General issues relating to Medicare, Medicaid, disproportionate share hospital payment, 340B, and COVID-19 relief. H.R. 4538 - Closing Loopholes for Orphan Drugs Act S. 4160, H.R. 7838 H.R. 6800 - The Heroes Act H.R. 8337 - Continuing Appropriations Act, 2021 and Other Extensions Act H.R. 925 - The HEROES Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Medicare/Medicaid
General issues relating to Medicare, Medicaid, disproportionate share hospital payment, 340B, and COVID-19 relief. H.R. 4538 - Closing Loopholes for Orphan Drugs Act S. 4160, H.R. 7838 H.R. 6800 - The Heroes Act H.R. 8337 - Continuing Appropriations Act, 2021 and Other Extensions Act H.R. 925 - The HEROES Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Medicare/Medicaid
Issues relating to the 340B drug pricing program. H.R. 4538 - Closing Loopholes for Orphan Drugs Act S. 4160, H.R. 7838 H.R. 6800 - The Heroes Act H.R. 8337 - Continuing Appropriations Act, 2021 and Other Extensions Act H.R. 925 - The HEROES Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Health Issues
Issues relating to the 340B drug pricing program. H.R. 4538 - Closing Loopholes for Orphan Drugs Act S. 4160, H.R. 7838 H.R. 6800 - The Heroes Act H.R. 8337 - Continuing Appropriations Act, 2021 and Other Extensions Act H.R. 925 - The HEROES Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Medicare/Medicaid
340B Drug Discount Program H.R. 1763, S. 348 - Resident Physician Shortage Reduction Act Graduate Medical Education Disproportionate Share Hospital payments Childrens Health Insurance Program Medicare Dependent Hospital Program (MDH) Medicaid Low Volume Payments (LV) Federal Medical Assistance Percentage Extension Inpatient Prospective Payment System Outpatient Prospective Payment System Bad debt/charity care Hospital Outpatient Department payments H.R. 2439, S. 2892 - Opioid Workforce Act H.R. 1358 - Advancing Medical Resident Training in Community Hospitals Act of 2019 S. 4160 - To maintain hospital 340B eligibility during the COVID-19 public health emergency
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Health Issues
HEROES Act H.R. 6800/COVID 4 Supplemental- provisions related to funding relief for hospitals and healthcare providers; Issues related to COVID-19 pandemic response for healthcare providers and hospitals H.R. 748; S. 3548 Coronavirus Aid, Relief, and Economic Security (CARES) Act - implementation of provisions related to funding relief for hospitals and healthcare providers S. 4160 - provisions related to section 340B of the Public Health Service Act H.R.6788; S.3599 Healthcare Workforce Resilience Act - provisions on the allocation of unused visas for healthcare professionals
Client expense: Not reported · Firm income: $9,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Health Issues
HEROES Act H.R. 6800/COVID 4 Supplemental- provisions related to funding relief for hospitals and healthcare providers; Issues related to COVID-19 pandemic response for healthcare providers and hospitals H.R. 748; S. 3548 Coronavirus Aid, Relief, and Economic Security (CARES) Act - implementation of provisions related to funding relief for hospitals and healthcare providers S. 4160 - provisions related to section 340B of the Public Health Service Act H.R.6788; S.3599 Healthcare Workforce Resilience Act - provisions on the allocation of unused visas for healthcare professionals
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Health Issues
HEROES Act H.R. 6800/COVID 4 Supplemental- provisions related to funding relief for hospitals and healthcare providers; Issues related to COVID-19 pandemic response for healthcare providers and hospitals H.R. 748; S. 3548 Coronavirus Aid, Relief, and Economic Security (CARES) Act - implementation of provisions related to funding relief for hospitals and healthcare providers S. 4160 - provisions related to section 340B of the Public Health Service Act H.R.6788; S.3599 Healthcare Workforce Resilience Act - provisions for allocation of unused visas for healthcare professionals
Client expense: $120,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Health Issues
COVID-19 crisis - Engaged with Congress and the administration to advocate for greater regulatory flexibility and appropriate reimbursement for hospitals through development, passage and ongoing implementation of coronavirus relief legislation: Coronavirus Aid Relief and Economic Security (CARES) Act (H.R. 748) Coronavirus Preparedness and Response Supplemental Appropriations Act (H.R. 6074) Families First Coronavirus Response Act (H.R. 6201) Paycheck Protection Act and Health Care Enhancement Act (H.R. 266) HEROES Act (HR 3) Hospital Group Purchasing - Offered recommendations and insights to support access to essential personal protective equipment, medications and supplies for hospitals treating patients and supply chain stability for the national response to the COVID-19 crisis. Provider Relief Fund - Urged Congress to increase funding available for the Provider Relief Fund, and encouraged HHS to rapidly deploy the funding for hospitals. Liability protections - Advocated for Congress to include liability protections for health care workers and facilities responding to the COVID-19 crisis. Prescription Drug Pricing - Monitored ongoing negotiations to reduce prescription drug prices. Engaged to clarify provisions in the House (H.R. 3) and Senate (S. 2543) drug pricing bills. 340B Drug Pricing Program - Supported legislation to ensure hospitals eligible for the 340B Drug Pricing Program do not lose eligibility due to changing patient mix during the COVID-19 crisis. Advocated for preserving the current structure of the program (S. 4160). Surprise Billing - Supported inclusion of provisions to provide for an independent dispute resolution process in legislation to address surprise bills (H.R. 3630; H.R. 2328; S. 1895).
Client expense: $260,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE
2020 · second_quarter · Pharmacy
S 4160 340B Enable certain hospitals that were participating in or applied for the drug discount program under section 340B of the public health service act prior to the COVID-19 public health emergency to temporarily maintain eligibility for program
Client expense: $200,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE